Form4insider filings, from the source

SEC Form 4 · accession 0000921895-26-001575

LIFECORE BIOMEDICAL, INC. \DE\ · LFCR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Christopher S Kiper
Director · 10% Owner
Legion Partners, L.P. I
Director · 10% Owner
Legion Partners, L.P. II
Director · 10% Owner
Legion Partners Holdings, LLC
Director · 10% Owner
Legion Partners, LLC
Director · 10% Owner
Raymond T. White
Director · 10% Owner
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001005286

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5,F6Jun 4, 2026A25,907—A103,482D
Common StockF1,F7holding———4,084,268IBy: Legion Partners, L.P. I
Common StockF1,F8holding———319,286IBy: Legion Partners, L.P. II
Common StockF1,F9holding———200IBy: Legion Partners Holdings, LLC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Christopher S. Kiper, a Managing Director of Legion Partners Asset Management, is a director of the Issuer. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the Reporting Persons (other than Mr. Kiper) may be deemed a director by deputization by virtue of Mr. Kiper's representation on the Board of the Issuer.